title: Interspecies difference of luteolin and apigenin after oral administration of Chrysanthemum morifolium extract and prediction of human pharmacokinetics.
abstract: The aims of the present study were to study the interspecies difference in the pharmacokinetics of luteolin and apigenin occurring in Chrysanthemum morifolium extract (CME) among rats, beagle dogs, mini-pigs, and humans, and compared the human pharmacokinetic parameters with the data predicted from the above three animals. The plasma concentrations of luteolin and apigenin were determined with a RP-HPLC method. An interspecies difference of pharmacokinetics was found, especially between rats and other species, the plasma concentration of luteolin was much lower than that of apigenin in rats, although the content of luteolin in CME was higherthan that of apigenin, whereas the plasma concentration of luteolin was much higher than that of apigenin in dogs, mini-pigs and humans. Animal scale-up of some pharmacokinetic parameters of luteolin and apigenin were also performed after rats, beagle dogs, mini-pigs and humans were orally given CME at dosages of 400 mg/kg, 102 mg/kg, 90 mg/kg, and 20 mg/kg, respectively. Linear relationships were obtained between log mean retention time (MRT) and log species body weight (W) (kg), and log elimination half-life (t1/2) (h) and logW. The corresponding allometric equations were MRT=9.382W(0.1711) (R2 = 0.9999) and t1/2 = 4.811W(0.1093) (R2 = 0.9013) for luteolin, MRT = 12.53W(0.0356) (R2 = 0.9980) and t1/2 = 7.940W(0.0294) (R2 = 0.9258) for apigenin, respectively. The predicted human pharmacokinetic parameters (MRT and t1/2) by an allometric approach were 18.6 h and 7.46 h for luteolin, 14.3 h and 8.95 h for apigenin, respectively, which were close to the values obtained from humans (20 mg CME/kg) in the present study. The study has demonstrated the possibility to extrapolate the pharmacokinetic behavior of flavonoids from animals to humans.
authors.affiliation: Department of Pharmaceutical Analysis and Drug Metabolism, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, P.R. China.
authors.forename: L P
authors.initials: LP
authors.lastname: Li
authors.forename: X D
authors.initials: XD
authors.lastname: Wu
authors.forename: Z J
authors.initials: ZJ
authors.lastname: Chen
authors.forename: S Y
authors.initials: SY
authors.lastname: Sun
authors.forename: J F
authors.initials: JF
authors.lastname: Ye
authors.forename: S
authors.initials: S
authors.lastname: Zeng
authors.forename: H D
authors.initials: HD
authors.lastname: Jiang
mesh_terms: D000328:Adult; D000818:Animals; D047310:Apigenin / Q000493:pharmacokinetics*; D019540:Area Under Curve; D002851:Chromatography, High Pressure Liquid; D031202:Chrysanthemum / Q000737:chemistry*; D004285:Dogs; D005100:Expectorants / Q000493:pharmacokinetics*; D005260:Female; D005544:Forecasting; D006207:Half-Life; D006801:Humans; D047311:Luteolin / Q000493:pharmacokinetics*; D008297:Male; D010936:Plant Extracts / Q000493:pharmacokinetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D013045:Species Specificity; D013552:Swine; D013556:Swine, Miniature
chemical_list: D005100:Expectorants; D010936:Plant Extracts; D047310:Apigenin; D047311:Luteolin